Kenneth French, director of clinical operations at VAP Diagnostics, says VAP’s predecessor, Atherotech, had about 400 employees when it shut the doors, and VAP Diagnostics now has about 40. Re-establishing confidence with customers surprised by the interruption will take time, he says. Photos by Cary Norton It was about a year…
A Life-Critical Hedge Bet
VAP Diagnostics’ cholesterol test solves the 60 percent inaccuracy of standard tests. New investors bet this critical technology will flourish, after an earlier fumble by private equity.
